Is mometasone furoate aqueous nasal spray (MFNS) effective in reducing symptoms in acute recurrent sinusitis?
McConaghy
J R
JR
The Toledo Hospital Family Practice Residency, Ohio, USA. john.mcconaghy.md@promedica.org
D000208:Acute Disease; D000280:Administration, Inhalation; D000336:Aerosols; D018926:Anti-Allergic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007249:Inflammation; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000494:pharmacology / Q000627:therapeutic use*; D012008:Recurrence; D012720:Severity of Illness Index; D012852:Sinusitis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D000336:Aerosols; D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011244:Pregnadienediols; D000068656:Mometasone Furoate